Alkermes Q3 net income falls 80% year over year to $16.3 million

Bitget2026/11/03 13:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Alkermes’ third-quarter 2026 GAAP net income fell 80% year over year to $16.3 million.
Revenue rose 22% year over year to $480.1 million.
Orexin programs delivered clinical proof-of-concept data in ADHD and entered a phase 2 study in major depressive disorder.
The company reiterated its 2026 financial expectations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-444381), on November 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alkermes Q3 net income falls 80% year over year to $16.3 million

You may also like

Crypto prices